|
Prognostic factors
Citations 1-10 of 22 total displayed.
|
Most recent content
(1 Feb 2004):
|
- ORIGINAL ARTICLES
Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers
- Mahmoud El-Tamer, Donna Russo, Andrea Troxel, Lourdes P. Bernardino, Robert Mazziotta, Alison Estabrook, Beth-Ann Ditkoff, Freya Schnabel, and Mahesh Mansukhani
Ann. Surg. Oncol. 2004; 11: 157-164.
[Abstract]
[Full text]
[PDF]
|
Past content
(since May 2000):
|
- ORIGINAL ARTICLES
Breast Cancer Survival According to Number of Nodes Removed
- David N. Krag and Richard M. Single
Ann. Surg. Oncol. 2003; 10: 1152-1159.
[Abstract]
[Full text]
[PDF]
- ORIGINAL ARTICLES
Breast Cancer Survival According to Number of Nodes Removed
- David N. Krag and Richard M. Single
Ann. Surg. Oncol. 10.1245/ASO.2003.03.073.
[Abstract]
[PDF]
- ORIGINAL ARTICLES
Breast Cancer in Women With Recent Exposure to Fertility Medications is Associated With Poor Prognostic Features
- Nava Siegelmann-Danieli, Ada Tamir, Hanna Zohar, Moshe Z. Papa, Lika L. Chetver, Zehava Gallimidi, Moshe E. Stein, and Abraham Kuten
Ann. Surg. Oncol. 2003; 10: 1031-1038.
[Abstract]
[Full text]
[PDF]
- ORIGINAL ARTICLES
Breast Cancer in Women with Recent Exposure to Fertility Medications is Associated with Poor Prognostic Features
- Nava Siegelmann-Danieli, Ada Tamir, Hanna Zohar, Moshe Z. Papa, Lika L. Chetver, Zehava Gallimidi, Moshe E. Stein, and Abraham Kuten
Ann. Surg. Oncol. 10.1245/ASO.2003.03.068.
[Abstract]
[PDF]
- ORIGINAL ARTICLES
Nipple Aspirate Fluid Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Urokinase-Type Plasminogen Activator Receptor Predicts Breast Cancer Diagnosis and Advanced Disease
- Wenyi Qin, Weizhu Zhu, Colette Wagner-Mann, and Edward R. Sauter
Ann. Surg. Oncol. 2003; 10: 948-953.
[Abstract]
[Full text]
[PDF]
- ORIGINAL ARTICLES
Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome
- Lisa A. Newman, Nat L. Pernick, Volkan Adsay, Kathryn A. Carolin, Philip I. Philip, Susan Sipierski, David L. Bouwman, Mary A. Kosir, Michael White, and Daniel W. Visscher
Ann. Surg. Oncol. 2003; 10: 734-739.
[Abstract]
[Full text]
[PDF]
- ORIGINAL ARTICLES
Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer
- Rosa F. Hwang, Savitri Krishnamurthy, Kelly K. Hunt, Nadeem Mirza, Frederick C. Ames, Barry Feig, Henry M. Kuerer, S. Eva Singletary, Gildy Babiera, Funda Meric, Jeri S. Akins, Jessica Neely, and Merrick I. Ross
Ann. Surg. Oncol. 2003; 10: 248-254.
[Abstract]
[Full text]
[PDF]
- ORIGINAL ARTICLES
The Clinical Significance of Cytokeratin-Positive Cells in Lymph Nodes at the Time of Mastectomy From Patients With Ductal Carcinoma-In-Situ
- Rohit Tamhane, Jane E. Dahlstrom, Dugald D. McCallum, and John M. Buckingham
Ann. Surg. Oncol. 2002; 9: 999-1003.
[Abstract]
[Full text]
[PDF]
- ORIGINAL ARTICLES
A Prospective Trial of Preoperative Chemotherapy in Resectable Breast Cancer: Predictors of Breast-Conservation Therapy Feasibility
- Lisa A. Newman, Aman U. Buzdar, S. Eva Singletary, Henry M. Kuerer, Thomas Buchholz, Frederick C. Ames, Merrick I. Ross, and Kelly K. Hunt
Ann. Surg. Oncol. 2002; 9: 228-234.
[Abstract]
[Full text]
[PDF]
|
|
